Clinical Trial Update: Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 randomized trial comparing paclitaxel plus carboplatin versus paclitaxel plus epirubicin in metastatic breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Epirubicin (epirubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Metastatic Breast Cancer | Phase 4 | Status: UNKNOWN